IBDEI16L ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20858,1,4,0)
 ;;=4^Dysuria
 ;;^UTILITY(U,$J,358.3,20858,2)
 ;;=^37716
 ;;^UTILITY(U,$J,358.3,20859,0)
 ;;=789.30^^112^1293^34
 ;;^UTILITY(U,$J,358.3,20859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20859,1,3,0)
 ;;=3^789.30
 ;;^UTILITY(U,$J,358.3,20859,1,4,0)
 ;;=4^Pelvic Abdominal Mass
 ;;^UTILITY(U,$J,358.3,20859,2)
 ;;=^917
 ;;^UTILITY(U,$J,358.3,20860,0)
 ;;=614.9^^112^1293^35
 ;;^UTILITY(U,$J,358.3,20860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20860,1,3,0)
 ;;=3^614.9
 ;;^UTILITY(U,$J,358.3,20860,1,4,0)
 ;;=4^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,20860,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,20861,0)
 ;;=599.0^^112^1293^45
 ;;^UTILITY(U,$J,358.3,20861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20861,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,20861,1,4,0)
 ;;=4^Urin Tract Infection Nos
 ;;^UTILITY(U,$J,358.3,20861,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,20862,0)
 ;;=218.9^^112^1293^46
 ;;^UTILITY(U,$J,358.3,20862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20862,1,3,0)
 ;;=3^218.9
 ;;^UTILITY(U,$J,358.3,20862,1,4,0)
 ;;=4^Uterine Fibroids
 ;;^UTILITY(U,$J,358.3,20862,2)
 ;;=^68944
 ;;^UTILITY(U,$J,358.3,20863,0)
 ;;=618.1^^112^1293^47
 ;;^UTILITY(U,$J,358.3,20863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20863,1,3,0)
 ;;=3^618.1
 ;;^UTILITY(U,$J,358.3,20863,1,4,0)
 ;;=4^Uterine Prolapse
 ;;^UTILITY(U,$J,358.3,20863,2)
 ;;=^124773
 ;;^UTILITY(U,$J,358.3,20864,0)
 ;;=112.1^^112^1293^48
 ;;^UTILITY(U,$J,358.3,20864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20864,1,3,0)
 ;;=3^112.1
 ;;^UTILITY(U,$J,358.3,20864,1,4,0)
 ;;=4^Vaginitis, Candidal
 ;;^UTILITY(U,$J,358.3,20864,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,20865,0)
 ;;=099.53^^112^1293^49
 ;;^UTILITY(U,$J,358.3,20865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20865,1,3,0)
 ;;=3^099.53
 ;;^UTILITY(U,$J,358.3,20865,1,4,0)
 ;;=4^Vaginitis, Chlamydial
 ;;^UTILITY(U,$J,358.3,20865,2)
 ;;=^293988
 ;;^UTILITY(U,$J,358.3,20866,0)
 ;;=131.01^^112^1293^50
 ;;^UTILITY(U,$J,358.3,20866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20866,1,3,0)
 ;;=3^131.01
 ;;^UTILITY(U,$J,358.3,20866,1,4,0)
 ;;=4^Vaginitis, Trichonomal
 ;;^UTILITY(U,$J,358.3,20866,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,20867,0)
 ;;=592.0^^112^1293^30
 ;;^UTILITY(U,$J,358.3,20867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20867,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,20867,1,4,0)
 ;;=4^Kidney Stones
 ;;^UTILITY(U,$J,358.3,20867,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,20868,0)
 ;;=627.2^^112^1293^44
 ;;^UTILITY(U,$J,358.3,20868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20868,1,3,0)
 ;;=3^627.2
 ;;^UTILITY(U,$J,358.3,20868,1,4,0)
 ;;=4^Symptomatic Menopause
 ;;^UTILITY(U,$J,358.3,20868,2)
 ;;=^328735
 ;;^UTILITY(U,$J,358.3,20869,0)
 ;;=622.10^^112^1293^20
 ;;^UTILITY(U,$J,358.3,20869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20869,1,3,0)
 ;;=3^622.10
 ;;^UTILITY(U,$J,358.3,20869,1,4,0)
 ;;=4^Dysplasia of Cervix
 ;;^UTILITY(U,$J,358.3,20869,2)
 ;;=^331546
 ;;^UTILITY(U,$J,358.3,20870,0)
 ;;=622.11^^112^1293^21
 ;;^UTILITY(U,$J,358.3,20870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20870,1,3,0)
 ;;=3^622.11
 ;;^UTILITY(U,$J,358.3,20870,1,4,0)
 ;;=4^Dysplasia of Cervix, Mild
 ;;^UTILITY(U,$J,358.3,20870,2)
 ;;=^331547
 ;;^UTILITY(U,$J,358.3,20871,0)
 ;;=622.12^^112^1293^22
 ;;^UTILITY(U,$J,358.3,20871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20871,1,3,0)
 ;;=3^622.12
 ;;^UTILITY(U,$J,358.3,20871,1,4,0)
 ;;=4^Dysplasia of Cervix, Moderate
 ;;^UTILITY(U,$J,358.3,20871,2)
 ;;=^331548
 ;;^UTILITY(U,$J,358.3,20872,0)
 ;;=V72.40^^112^1293^38
 ;;^UTILITY(U,$J,358.3,20872,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI16L
